Hormonal steroid contraceptives. IV. Adverse reactions and management of the patient.
D000804:Angiotensin II / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced; D002241:Carbohydrates / Q000097:blood; D002779:Cholestasis / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects* / Q000494:pharmacology; D005260:Female; D005881:Gingiva / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007565:Jaundice / Q000139:chemically induced; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects; D012083:Renin / Q000097:blood; D012867:Skin / Q000187:drug effects; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D001786:Blood Glucose; D001798:Blood Proteins; D002241:Carbohydrates; D003276:Contraceptives, Oral; D008055:Lipids; D000804:Angiotensin II; D012083:Renin